HE homepage

Samsung

Xealth’s data sharing platform will be used to make use of health information gathered from everyday devices like the Samsung Galaxy Smartwatch, the companies said.

the words "FDA recall" on a board

Ballard Closed Suction Systems will need to be returned to the manufacturer for a refund due to the high risk of a potentially fatal infection stemming from their use.

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

CMS has finalized a new national coverage determination for T-TEER, sometimes known as transcatheter tricuspid valve repair. Abbott's TriClip is the only device approved by the FDA for T-TEER, but other treatment options are under development.

An example of artificial intelligence automated coronary artery calcium scoring shown by Coreline at ACC23. The AI also identifies and color codes the anatomy so help show the reviewing radiologist or cardiac imager what and where things were calculated. #ACC #ACC23

Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence. 

artificial intelligence in critical care ICU

The AI revolution in healthcare is less about technological advancement than change management vis-à-vis human relations. This may be nowhere more true than in critical care. 

Thumbnail

The pharmacy chain said it plans to appeal the ruling. The complaint was brought by a former employee turned whistleblower who alleged that Omnicare had billed the government for millions of unnecessary prescriptions.

Around the web

The Heart Rhythm Society and its new advocacy arm plan on pushing CMS to include certain policy improvements in the 2026 MPFS.

While Kardium raised $250 million in an oversubscribed funding round, Field Medical raised $35 million. Both companies are focused on designing and developing new pulsed field ablation technologies to help treat challenging arrhythmias. 

Johnson & Johnson MedTech has received reports of its Automated Impella Controller failing to connect properly with Impella heart pumps. If this happens, the FDA warned, it may put patients at risk.